+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Drugs Market Research Reports

From
From
Acute Decompensated Heart Failure - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Acute Decompensated Heart Failure - Global Clinical Trials Review, 2025

  • Clinical Trials
  • March 2025
  • 191 Pages
  • Global
From
From
Stroke - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Stroke - Global Clinical Trials Review, 2025

  • Clinical Trials
  • January 2025
  • 2461 Pages
  • Global
From
Hyperlipidemia: Competitive Landscape - Product Thumbnail Image

Hyperlipidemia: Competitive Landscape

  • Report
  • January 2025
  • 99 Pages
  • Global
From
From
From
Hereditary Angioedema Market Report and Forecast 2025-2034 - Product Thumbnail Image

Hereditary Angioedema Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
Loading Indicator

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more